Show simple item record

dc.contributor.authorEADV Task Force on Quality of Life
dc.contributor.authorFinlay, A Y
dc.contributor.authorSalek, M S
dc.contributor.authorAbeni, D
dc.contributor.authorTomás-Aragonés, L
dc.contributor.authorvan Cranenburgh, O D
dc.contributor.authorEvers, A W M
dc.contributor.authorJemec, G B E
dc.contributor.authorLinder, D
dc.contributor.authorManolache, L
dc.contributor.authorMarrón, S E
dc.contributor.authorPrinsen, C A C
dc.contributor.authorSusitaival, P
dc.contributor.authorChernyshov, P V
dc.date.accessioned2020-07-09T00:06:06Z
dc.date.available2020-07-09T00:06:06Z
dc.date.issued2017-03
dc.identifier.citationEADV Task Force on Quality of Life , Finlay , A Y , Salek , M S , Abeni , D , Tomás-Aragonés , L , van Cranenburgh , O D , Evers , A W M , Jemec , G B E , Linder , D , Manolache , L , Marrón , S E , Prinsen , C A C , Susitaival , P & Chernyshov , P V 2017 , ' Why quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Life ' , Journal of the European Academy of Dermatology and Venereology , vol. 31 , no. 3 , pp. 424-431 . https://doi.org/10.1111/jdv.13985
dc.identifier.issn0926-9959
dc.identifier.urihttp://hdl.handle.net/2299/22943
dc.description© 2016 European Academy of Dermatology and Venereology.
dc.description.abstractThe aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofJournal of the European Academy of Dermatology and Venereology
dc.subjectClinical Decision-Making
dc.subjectCommunication
dc.subjectCost of Illness
dc.subjectDermatology/organization & administration
dc.subjectHumans
dc.subjectPatient Comfort
dc.subjectPhysician-Patient Relations
dc.subjectPrognosis
dc.subjectQuality of Life
dc.subjectReferral and Consultation
dc.subjectSkin Diseases/complications
dc.subjectSurveys and Questionnaires
dc.titleWhy quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Lifeen
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.identifier.urlhttp://orca.cf.ac.uk/101667/
rioxxterms.versionofrecord10.1111/jdv.13985
rioxxterms.typeOther


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record